secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001640334-26-000574
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences closes $11M private placement; expects to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Gross proceeds $11.0M from sale of 3.19M common shares (or pre-funded warrants) and 6.38M common warrants at $3.45/unit.
- Net proceeds of $10.03M to be used for working capital, corporate purposes, and repayment of bridge debt.
- Common warrants exercisable at $3.20 for 5.5 years; potential additional proceeds of $20.4M if fully cash-exercised.
- Proceeds push stockholders' equity above $2.5M threshold; company awaiting Nasdaq confirmation of compliance.
- H.C. Wainwright acted as placement agent, receiving 8% cash fee plus warrants for 255,073 shares at $4.3125.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000574/0001640334-26-000574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000574/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer